Aplex Bio
PrivateLast Round
Grant
Nov 2, 2023
Total Funding Raised
$1.45M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aplex Bio operates in Healthcare & Life Sciences and is based in Solna. Its latest recorded funding round was a Grant round in November 2023.
Aplex Bio is a biotechnology company that develops hyperplexed PCR solutions for the detection of multiple biomarkers in a single sample.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aplex Bio Comparables
Compare Aplex Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Signal Bioscience | 78% | |
| ChromaCode | 78% | |
| YouSeq | 71% |
For institutional investors. Book with your work email.
Aplex Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 2, 2023 | ||||
| Seed | Mar 11, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aplex Bio Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 954% to 3.7K.
- May 15, 2026
Monthly visitors grew 41% MoM, reaching 2K.
For institutional investors. Book with your work email.
Aplex Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aplex Bio's valuation, stock price, and market status.
Is Aplex Bio a public or private company?
Aplex Bio is a private company.
What is the current stock price of Aplex Bio?
Aplex Bio is a private company, so its shares have no public market price. Caplight tracks Aplex Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aplex Bio worth (valuation)?
Valuation information for Aplex Bio is not publicly available.
Can I buy Aplex Bio stock?
Aplex Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aplex Bio's last funding round?
Aplex Bio's most recent funding round was Grant on November 2, 2023.
Who are the main investors in Aplex Bio?
Key investors in Aplex Bio include Vinnova, NOME.
Will Aplex Bio IPO soon?
No public IPO plans have been announced for Aplex Bio.
How can I track Aplex Bio secondary market activity?
Caplight tracks bids, offers, and trades in Aplex Bio's shares on secondary markets.